About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT07238244

Risk Factors for Recurrence of Trigeminal Neuralgia After Percutaneous Balloon Compression

The goal of this observational study is to develop and validate a machine learning-based model for predicting pain recurrence risk after percutaneous balloon compression (PBC) in adult patients with p...

Lead sponsor: Second Xiangya Hospital of Central South University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Second Xiangya Hospital of Central South University

Collaborators

Yueyang Hospital of Traditional Chinese Medicine

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Aged ≥ 18 years.
•2. Meet the diagnostic criteria for primary trigeminal neuralgia according to the International Classification of Headache Disorders, 3rd edition (ICHD-3).
•3. Undergo the first PBC treatment.
•4. Have complete preoperative clinical data, imaging data, and intraoperative records.
•5. Have at least one postoperative follow-up record available for determining the recurrence status.

Exclusion Criteria

•1. Secondary trigeminal neuralgia (e.g., caused by cerebellopontine angle tumors, multiple sclerosis, etc.).
•2. Missing rate of key predictor variables (e.g., balloon shape) or outcome variables \> 15%.
•3. Postoperative loss to follow-up (defined as no follow-up records available).

Related studies

The Will Erwin Headache Research Center - Cluster Headache Study

NCT02910323 · Cluster Headache, Cluster Headaches and Other Trigeminal Autonomic Cephalgias, and more

Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.

NCT06290661 · Postherpetic Neuralgia, Peripheral Neuropathic Pain, and more

Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia

NCT06890897 · Zoster; Herpes, Trigeminal Neuralgia (Etiology)

RECRUITINGPhase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia

NCT05152368 · Peripheral Neuropathy, Trigeminal Neuralgia

Impact of Individual Radiosensitivity on Late Toxicities of Radiosurgery in Essential Trigeminal Neuralgia

NCT06863324 · Trigeminal Neuralgia Treated by Radiosurgery

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 20, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment700

Start dateDec 2025

Last updatedNov 20, 2025

Condition

Trigeminal Neuralgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions